Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

Overview of attention for article published in Cochrane database of systematic reviews, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog

twitter: 6 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 47 Mendeley

Summary Blogs X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators

Article in Journal of Fungi (September 2024)

Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses

Article in European Respiratory Journal (February 2024)

Subtherapeutic triazole concentrations as result of a drug-drug interaction with lumacaftor/ivacaftor

Article in Journal of Cystic Fibrosis (January 2024)